EconomyBayer Plans $2.2 Billion US Drug Plant Amid Tariff Pressure
Bayer plans to invest $2.2 billion in a new drug manufacturing site in Ohio. The move is the latest in a series of investment pledges by European pharmaceutical companies facing pressure from the Trump administration to lower drug prices and expand US manufacturing.
B
Bloomberg News★★★☆☆2026-10-02 19:30Original
Bayer Plans $2.2 Billion US Drug Plant Amid Tariff Pressure
Economy